Ian F. Smith

Insider Reports History

Location
C/O Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley, NY
Signature
/s/ Jonathan Allan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian F. Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Solid Biosciences Inc. Director Common Stock 127K $781K $6.17 Oct 6, 2025 Direct
Foghorn Therapeutics Inc. Director Stock Option (right to buy) 25K $120K $4.79 Jun 17, 2025 Direct
Solid Biosciences Inc. Director Restricted Stock Units 4.57K $73.2K $5.34 Oct 6, 2025 Direct
Stoke Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 570K Oct 8, 2025 Direct
Stoke Therapeutics, Inc. Chief Executive Officer, Director Restricted Stock Units 380K Oct 8, 2025 Direct
Solid Biosciences Inc. Director Director Stock Option (Right to Buy) 77.5K Jun 12, 2025 Direct
Solid Biosciences Inc. Director Stock Option (Right to Buy) 22.1K Jan 6, 2025 Direct

Insider Reports Filed by Ian F. Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STOK Stoke Therapeutics, Inc. Oct 8, 2025 2 $0 4 Oct 14, 2025 Chief Executive Officer, Director
SLDB Solid Biosciences Inc. Oct 6, 2025 2 $0 4 Oct 7, 2025 Director
SLDB Solid Biosciences Inc. Jul 6, 2025 2 $0 4 Jul 8, 2025 Director
FHTX Foghorn Therapeutics Inc. Jun 17, 2025 1 $120K 4 Jun 17, 2025 Director
SLDB Solid Biosciences Inc. Jun 12, 2025 1 $0 4 Jun 13, 2025 Director
SLDB Solid Biosciences Inc. Apr 6, 2025 2 $0 4 Apr 8, 2025 Director
STOK Stoke Therapeutics, Inc. Mar 20, 2025 1 $0 4 Mar 20, 2025 Interim CEO, Director
SLDB Solid Biosciences Inc. Jan 3, 2025 4 $0 4 Jan 7, 2025 Director
SLDB Solid Biosciences Inc. Oct 3, 2024 2 $0 4 Oct 4, 2024 Director
SLDB Solid Biosciences Inc. Jul 3, 2024 2 $0 4 Jul 5, 2024 Director
FHTX Foghorn Therapeutics Inc. Jun 26, 2024 1 $88.3K 4 Jun 28, 2024 Director
SLDB Solid Biosciences Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
STOK Stoke Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
SLDB Solid Biosciences Inc. Apr 3, 2024 2 $0 4 Apr 5, 2024 Director
SLDB Solid Biosciences Inc. Jan 3, 2024 4 $0 4 Jan 5, 2024 Director
FHTX Foghorn Therapeutics Inc. Dec 8, 2023 1 $0 4 Dec 12, 2023 Director
SLDB Solid Biosciences Inc. Oct 3, 2023 2 $0 4 Oct 5, 2023 Director
STOK Stoke Therapeutics, Inc. Sep 19, 2023 1 $0 4 Sep 20, 2023 Director
STOK Stoke Therapeutics, Inc. Sep 19, 2023 0 $0 3 Sep 20, 2023 Director
SLDB Solid Biosciences Inc. Jul 3, 2023 2 $0 4 Jul 6, 2023 Director
FHTX Foghorn Therapeutics Inc. Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
SLDB Solid Biosciences Inc. Apr 3, 2023 3 $0 4 Jun 8, 2023 Director
SLDB Solid Biosciences Inc. Jan 3, 2023 4 $0 4 Jan 5, 2023 Director
SLDB Solid Biosciences Inc. Dec 13, 2022 1 $0 4 Dec 15, 2022 Director
SLDB Solid Biosciences Inc. Dec 2, 2022 1 $0 4 Dec 5, 2022 Director
SLDB Solid Biosciences Inc. Oct 3, 2022 2 $0 4 Oct 4, 2022 Director
SLDB Solid Biosciences Inc. Jul 3, 2022 2 $0 4 Jul 6, 2022 Director
FHTX Foghorn Therapeutics Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
SLDB Solid Biosciences Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
SLDB Solid Biosciences Inc. Apr 3, 2022 2 $0 4 Apr 5, 2022 Director
SLDB Solid Biosciences Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 Director
FHTX Foghorn Therapeutics Inc. Jun 23, 2021 1 $0 4 Jun 24, 2021 Director
SLDB Solid Biosciences Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director
FHTX Foghorn Therapeutics Inc. Apr 27, 2021 0 $0 3/A Sep 13, 2022 Director